We evaluated pretreatment total lymphocyte count (TLC, marker of immunosuppression), neutrophil-to-lymphocyte ratio (NLR, marker of inflammation), and overall survival (OS) in patients with extensive-stage small-cell lung cancer (ES-SCLC).
http://ift.tt/2DZivSh
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου